TEAS RF New Application

BIONDIS

Synthon Biopharmaceuticals B.V

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88585565
Filing Date: 08/20/2019

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88585565
MARK INFORMATION
*MARK BIONDIS
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT BIONDIS
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Synthon Biopharmaceuticals B.V
*STREET Microweg 22
*CITY CM Nijmegen
*COUNTRY Netherlands
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
6545
LEGAL ENTITY INFORMATION
TYPE limited liability company
STATE/COUNTRY WHERE LEGALLY ORGANIZED Netherlands
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Biopharmaceutical preparations, substances and compositions; Biological and biochemical drug and Cultures for medical use; Biopharmaceutical active substances; Biopharmaceutical components and Ingredients, all of the above excluding for the treatment of neuromuscular diseases and disorders
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 010 
*IDENTIFICATION Surgical and medical devices, apparatus and instruments; Orthopedic articles; Injection apparatus for medical purposes
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 035 
*IDENTIFICATION Office functions relating to the registration of pharmaceutical preparations and components and Pharmaceutical drugs; Office functions relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration files; Business mediation in the purchase, sale and licensing of pharmaceutical registrations and pharmaceutical registration files
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 040 
*IDENTIFICATION Treatment of materials, including on request, for others, for the purpose of manufacturing pharmaceutical and biopharmaceutical preparations; Manufacture, for others, of pharmaceutical and biopharmaceutical preparations and raw materials for the pharmaceutical industry
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION Scientific and technological services and research relating thereto; Scientific and technological services relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration files; Pharmaceutical research services and Consultancy in this field; Biomedical research services and Consultancy in this field; Medical research and Consultancy in this field; Chemistry and biology laboratories; Laboratory (Scientific -) services; Development of pharmaceutical products and Ingredients; Information relating to medical and scientific research in the field of pharmaceutical preparations; Providing information on the results of clinical trials for pharmaceutical preparations; Quality control of products for the purpose of certification; Laboratory research and laboratory analysis; Research and design for the pharmaceutical industry; Research and development for others; Drug discovery; Testing in the context of quality control; Conducting clinical trials for pharmaceutical preparations; Conducting quality control of pharmaceutical preparations; providing information and Data relating to pharmaceutical, biopharmaceutical and Medical research and developments
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME E. Anthony Figg
ATTORNEY DOCKET NUMBER 3599-157
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Rothwell, Figg, Ernst & Manbeck, pc
INTERNAL ADDRESS Suite 800
STREET 607 14th Street NW
CITY Washington
STATE District of Columbia
COUNTRY United States
ZIP/POSTAL CODE 20005
FAX 202-783-6031
EMAIL ADDRESS PTO-TM-Email@rfem.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Leo M. Loughlin, Davide F. Schiavetti
DOMESTIC REPRESENTATIVE INFORMATION
NAME E. Anthony Figg
FIRM NAME Rothwell, Figg, Ernst & Manbeck, pc
INTERNAL ADDRESS Suite 800
STREET 607 14th Street NW
CITY Washington
STATE District of Columbia
COUNTRY United States
ZIP CODE 20005
FAX 202-783-6031
EMAIL ADDRESS PTO-TM-Email@rfem.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
CORRESPONDENCE INFORMATION
NAME E. Anthony Figg
FIRM NAME Rothwell, Figg, Ernst & Manbeck, pc
INTERNAL ADDRESS Suite 800
STREET 607 14th Street NW
CITY Washington
STATE District of Columbia
COUNTRY United States
ZIP/POSTAL CODE 20005
FAX 202-783-6031
*EMAIL ADDRESS PTO-TM-Email@rfem.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 5
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 1375
*TOTAL FEE PAID 1375
SIGNATURE INFORMATION
SIGNATURE /Leo M. Loughlin/
SIGNATORY'S NAME Leo M. Loughlin
SIGNATORY'S POSITION Attorney of Record, DC Bar Member
SIGNATORY'S PHONE NUMBER 202-783-6040
DATE SIGNED 08/20/2019



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88585565
Filing Date: 08/20/2019

To the Commissioner for Trademarks:

MARK: BIONDIS (Standard Characters, see mark)
The literal element of the mark consists of BIONDIS. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Synthon Biopharmaceuticals B.V, a limited liability company legally organized under the laws of Netherlands, having an address of
      Microweg 22
      CM Nijmegen 6545
      Netherlands

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Biopharmaceutical preparations, substances and compositions; Biological and biochemical drug and Cultures for medical use; Biopharmaceutical active substances; Biopharmaceutical components and Ingredients, all of the above excluding for the treatment of neuromuscular diseases and disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 010:  Surgical and medical devices, apparatus and instruments; Orthopedic articles; Injection apparatus for medical purposes
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 035:  Office functions relating to the registration of pharmaceutical preparations and components and Pharmaceutical drugs; Office functions relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration files; Business mediation in the purchase, sale and licensing of pharmaceutical registrations and pharmaceutical registration files
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 040:  Treatment of materials, including on request, for others, for the purpose of manufacturing pharmaceutical and biopharmaceutical preparations; Manufacture, for others, of pharmaceutical and biopharmaceutical preparations and raw materials for the pharmaceutical industry
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Scientific and technological services and research relating thereto; Scientific and technological services relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration files; Pharmaceutical research services and Consultancy in this field; Biomedical research services and Consultancy in this field; Medical research and Consultancy in this field; Chemistry and biology laboratories; Laboratory (Scientific -) services; Development of pharmaceutical products and Ingredients; Information relating to medical and scientific research in the field of pharmaceutical preparations; Providing information on the results of clinical trials for pharmaceutical preparations; Quality control of products for the purpose of certification; Laboratory research and laboratory analysis; Research and design for the pharmaceutical industry; Research and development for others; Drug discovery; Testing in the context of quality control; Conducting clinical trials for pharmaceutical preparations; Conducting quality control of pharmaceutical preparations; providing information and Data relating to pharmaceutical, biopharmaceutical and Medical research and developments
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The applicant hereby appoints E. Anthony Figg. Other appointed attorneys are Leo M. Loughlin, Davide F. Schiavetti. E. Anthony Figg of Rothwell, Figg, Ernst & Manbeck, pc, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      Suite 800
      607 14th Street NW
      Washington, District of Columbia 20005
      United States
      202-783-6031(fax)
      PTO-TM-Email@rfem.com (authorized).
The attorney docket/reference number is 3599-157.
E. Anthony Figg submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant hereby appoints E. Anthony Figg of Rothwell, Figg, Ernst & Manbeck, pc
      607 14th Street NW
      Suite 800
      Washington District of Columbia 20005
      United States
      202-783-6031(fax)
      PTO-TM-Email@rfem.com
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.

The applicant's current Correspondence Information:
      E. Anthony Figg
      Rothwell, Figg, Ernst & Manbeck, pc
      Suite 800
      607 14th Street NW
      Washington, District of Columbia 20005
      202-783-6031(fax)
      PTO-TM-Email@rfem.com (authorized).

Email Authorization: I authorize the USPTO to send email correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the email address provided in this application. I understand that a valid email address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $1375 has been submitted with the application, representing payment for 5 class(es).

Declaration

Declaration Signature

Signature: /Leo M. Loughlin/   Date: 08/20/2019
Signatory's Name: Leo M. Loughlin
Signatory's Position: Attorney of Record, DC Bar Member
Payment Sale Number: 88585565
Payment Accounting Date: 08/20/2019

Serial Number: 88585565
Internet Transmission Date: Tue Aug 20 15:16:15 EDT 2019
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XXX-2019082015161578
0309-88585565-610b1b3cb5c7ed3bbc3b31f046
1d3b5b87c9af3598237e2ca5736f2418f1abb526
-DA-16157080-20190820130801996302

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed